Cocrystal Pharma Inc reports results for the quarter ended in June - Earnings Summary

Cocrystal Pharma

14/08/2023 14:32

* Cocrystal Pharma Inc  COCP.OQ  reported a quarterly
adjusted
loss of 41 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 58 cents per share.
    * Reported revenue was zero​; analysts expected $266.67
thousand. 
    * Cocrystal Pharma Inc's reported EPS for the quarter was a
loss
of 41 cents​.
    * The mean earnings estimate of analysts had risen by
about 7.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Cocrystal Pharma Inc shares had risen by 20.9% this
quarter and
gained 48.2% so far this year.
    * The company reported a quarterly loss of $4.17 million.
    * Wall Street's median 12-month price target for Cocrystal
Pharma
Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.58          -0.41          Beat
 Mar. 31 2023      -0.67          -0.64          Beat
 Dec. 31 2022      -0.73          -0.55          Beat
 Sep. 30 2022      -0.48          -0.70          Missed